+91 8766 590 1366 sales@chemreports.com

Your Order

Home Reports

Biological API Drug Manufacturing global market

Biological API Drug Manufacturing global market

Global Biological API Drug Manufacturing Market Research Report 2025

This report on the global biological api drug manufacturing market research report 2025 offers a comprehensive analysis of market size, growth drivers, emerging tren

Pages: 210

Format: PDF

Date: 12-2025

Select Licence

Description Table of Content Key Players & Segment Request for Free Sample

Global Biological API Drug Manufacturing Market Report (2025–2035)

Market Prediction

Chem Reports predicts that the Biological API Drug Manufacturing Market was valued at USD [xxxx] in 2024 and is expected to reach USD [xxxx] by 2035, growing at a CAGR of [xx%] globally.

Market Overview

The Global Biological API Drug Manufacturing Market Report 2020 provides an extensive industry analysis of development components, patterns, flows, and market sizes. It calculates present and past market values to forecast potential market performance during the period 2025–2035.

This research study involved both primary and secondary data sources, covering:

  • Government policies and regulatory frameworks
  • Market environment and competitive landscape
  • Historical data and current market trends
  • Technological innovations and upcoming advancements
  • Technical progress in related industries

Impact of COVID-19

The COVID-19 outbreak in December 2019, declared a global public health emergency by the World Health Organization, significantly impacted the Biological API Drug Manufacturing Market in 2020. Supply chain disruptions, increased demand for vaccines and biologics, and accelerated investment in biomanufacturing capacity were key outcomes.

Market Segmentation

By Type

  • In-House Manufacturing
  • Contract Manufacturing

By Application

  • Monoclonal Antibody (mAb) Therapies
  • Vaccines
  • Insulin Therapies
  • Interferon Therapies
  • Others

Regional Analysis

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, etc.)
  • Asia-Pacific (China, India, Japan, Southeast Asia, etc.)
  • South America (Brazil, Argentina, etc.)
  • Middle East & Africa (Saudi Arabia, South Africa, etc.)

Key Players

  • Lonza
  • Boehringer Ingelheim BioXcellence
  • Celltrion
  • DSM
  • Samsung BioLogics
  • Fujifilm Diosynth Biotechnologies
  • Cytovance Biologics
  • AbbVie
  • Baxter
  • CEPiA Sanofi
  • GSK
  • Pfizer CentreOne
  • Sandoz
  • Vetter
  • Wuxi Biologics

The Biological API (Active Pharmaceutical Ingredient) Drug Manufacturing Market was valued at USD [xxxx] in 2024 and is projected to reach USD [xxxx] by 2035, growing at a CAGR of [xx%] globally. Biological APIs, including monoclonal antibodies, vaccines, and insulin therapies, are critical components of modern biopharmaceuticals. The market is driven by rising demand for biologics, expansion of contract manufacturing organizations (CMOs), and regulatory emphasis on quality and scalability.

Regional Analysis

  • North America: Largest market, driven by strong biopharma R&D, established CMOs, and regulatory frameworks (FDA).
  • Europe: Significant growth due to advanced biologics manufacturing hubs in Germany, Switzerland, and the U.K. Strict EMA regulations shape production standards.
  • Asia-Pacific: Fastest-growing region, led by China, India, and South Korea. Expansion of cost-efficient manufacturing and government support for biopharma innovation.
  • South America: Brazil and Argentina emerging with growing biologics demand and regional manufacturing initiatives.
  • Middle East & Africa: Early-stage market; increasing investment in healthcare infrastructure and partnerships with global CMOs.

Detailed Segmentation Analysis

By Type

  • In-House Manufacturing: Large pharma companies with dedicated biologics facilities.
  • Contract Manufacturing: CMOs offering scalable, cost-efficient solutions; fastest-growing segment.

By Application

  • Monoclonal Antibody (mAb) Therapies: Largest segment; oncology and autoimmune treatments.
  • Vaccines: High demand post-COVID and for emerging infectious diseases.
  • Insulin Therapies: Rising prevalence of diabetes globally.
  • Interferon Therapies: Applications in viral and immune-related conditions.
  • Others: Specialty biologics and biosimilars.

Porter’s Five Forces – List

  1. Competitive Rivalry: High – global players (Lonza, Samsung BioLogics, Wuxi Biologics) dominate.
  2. Threat of New Entrants: Moderate – high capital and regulatory barriers, but emerging biotech firms entering.
  3. Bargaining Power of Suppliers: Moderate – dependence on raw materials, cell lines, and specialized equipment.
  4. Bargaining Power of Buyers: High – pharma companies demand cost efficiency, scalability, and compliance.
  5. Threat of Substitutes: Low – biologics are unique therapies with limited alternatives.

SWOT Analysis

Strengths

  • Critical role in biologics and advanced therapies.
  • Strong demand across therapeutic areas.

Weaknesses

  • High capital and operational costs.
  • Complex regulatory compliance requirements.

Opportunities

  • Expansion of CMOs in Asia-Pacific.
  • Rising demand for biosimilars and personalized medicine.

Threats

  • Supply chain vulnerabilities.
  • Intense competition among global players.

Trend Analysis

  • Rapid growth of contract manufacturing for biologics.
  • Increasing focus on biosimilars and cost-effective therapies.
  • Technological innovation in cell culture, bioreactors, and continuous manufacturing.
  • Expansion of biologics pipelines in oncology, immunology, and rare diseases.

Drivers & Challenges

Drivers

  • Rising global demand for biologics.
  • Expansion of CMOs offering flexible capacity.
  • Regulatory push for quality and safety in biologics.

Challenges

  • High production costs and technical complexity.
  • Stringent regulatory approval processes.
  • Supply chain risks for raw materials and specialized equipment.

Value Chain Analysis

  1. Raw Material Suppliers: Cell lines, culture media, reagents, bioreactor equipment.
  2. Manufacturers: In-house pharma facilities and CMOs (Lonza, Samsung BioLogics, Wuxi Biologics).
  3. Quality & Regulatory Compliance: Adherence to FDA, EMA, and WHO standards.
  4. Distribution: Pharma companies, healthcare providers, and global supply chains.
  5. End-Use Applications: Monoclonal antibodies, vaccines, insulin, interferons, biosimilars.

Quick Recommendations for Stakeholders

  • Manufacturers: Invest in continuous manufacturing and digital bioprocessing to reduce costs.
  • Investors: Focus on Asia-Pacific CMOs and biosimilar opportunities.
  • Regulators: Strengthen harmonized global standards to streamline approvals.
  • Pharma Companies: Balance in-house and outsourced manufacturing for flexibility.
  • Suppliers: Secure resilient supply chains for critical raw materials and equipment.

Explore more report here-
https://chemreports.com/reports

1. Market Overview of Biological API Drug Manufacturing Market
    1.1 Biological API Drug Manufacturing Market Market Overview
        1.1.1 Biological API Drug Manufacturing Market Product Scope
        1.1.2 Market Status and Outlook
    1.2 Biological API Drug Manufacturing Market Market Size by Regions:
    1.3 Biological API Drug Manufacturing Market Historic Market Size by Regions
    1.4 Biological API Drug Manufacturing Market Forecasted Market Size by Regions
    1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
        1.5.1 North America
        1.5.2 East Asia
        1.5.3 Europe
        1.5.4 South Asia
        1.5.5 Southeast Asia
        1.5.6 Middle East
        1.5.7 Africa
        1.5.8 Oceania
        1.5.9 South America
        1.5.10 Rest of the World
    1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
        1.6.1 Covid-19 Impact: Global GDP Growth,  Projections
        1.6.2 Covid-19 Impact: Commodity Prices Indices
        1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Biological API Drug Manufacturing Market Sales Market by Type
    2.1 Global Biological API Drug Manufacturing Market Historic Market Size by Type
    2.2 Global Biological API Drug Manufacturing Market Forecasted Market Size by Type
    2.3 In-House manufacturing
    2.4 Contract manufacturing
3. Covid-19 Impact Biological API Drug Manufacturing Market Sales Market by Application
    3.1 Global Biological API Drug Manufacturing Market Historic Market Size by Application
    3.2 Global Biological API Drug Manufacturing Market Forecasted Market Size by Application
    3.3 Monoclonal Antibody (mAb) Therapies
    3.4 Vaccines
    3.5 Insulin Therapies
    3.6 Interferon Therapies
    3.7 Others
4. Covid-19 Impact Market Competition by Manufacturers
    4.1 Global Biological API Drug Manufacturing Market Production Capacity Market Share by Manufacturers
    4.2 Global Biological API Drug Manufacturing Market Revenue Market Share by Manufacturers
    4.3 Global Biological API Drug Manufacturing Market Average Price by Manufacturers
5. Company Profiles and Key Figures in Biological API Drug Manufacturing Market Business
    5.1 Lonza
        5.1.1 Lonza Company Profile
        5.1.2 Lonza Biological API Drug Manufacturing Market Product Specification
        5.1.3 Lonza Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin
    5.2 Boehringer Ingelheim BioXcellence
        5.2.1 Boehringer Ingelheim BioXcellence Company Profile
        5.2.2 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Market Product Specification
        5.2.3 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin
    5.3 Celltrion
        5.3.1 Celltrion Company Profile
        5.3.2 Celltrion Biological API Drug Manufacturing Market Product Specification
        5.3.3 Celltrion Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin
    5.4 DSM
        5.4.1 DSM Company Profile
        5.4.2 DSM Biological API Drug Manufacturing Market Product Specification
        5.4.3 DSM Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin
    5.5 Samsung BioLogics
        5.5.1 Samsung BioLogics Company Profile
        5.5.2 Samsung BioLogics Biological API Drug Manufacturing Market Product Specification
        5.5.3 Samsung BioLogics Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin
    5.6 Fujifilm Diosynth Biotechnologies
        5.6.1 Fujifilm Diosynth Biotechnologies Company Profile
        5.6.2 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Market Product Specification
        5.6.3 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin
    5.7 Cytovance Biologics
        5.7.1 Cytovance Biologics Company Profile
        5.7.2 Cytovance Biologics Biological API Drug Manufacturing Market Product Specification
        5.7.3 Cytovance Biologics Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin
    5.8 AbbVie
        5.8.1 AbbVie Company Profile
        5.8.2 AbbVie Biological API Drug Manufacturing Market Product Specification
        5.8.3 AbbVie Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin
    5.9 Baxter
        5.9.1 Baxter Company Profile
        5.9.2 Baxter Biological API Drug Manufacturing Market Product Specification
        5.9.3 Baxter Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin
    5.10 CEPiA Sanofi
        5.10.1 CEPiA Sanofi Company Profile
        5.10.2 CEPiA Sanofi Biological API Drug Manufacturing Market Product Specification
        5.10.3 CEPiA Sanofi Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin
    5.11 GSK
        5.11.1 GSK Company Profile
        5.11.2 GSK Biological API Drug Manufacturing Market Product Specification
        5.11.3 GSK Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin
    5.12 Pfizer CentreOne
        5.12.1 Pfizer CentreOne Company Profile
        5.12.2 Pfizer CentreOne Biological API Drug Manufacturing Market Product Specification
        5.12.3 Pfizer CentreOne Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin
    5.13 Sandoz
        5.13.1 Sandoz Company Profile
        5.13.2 Sandoz Biological API Drug Manufacturing Market Product Specification
        5.13.3 Sandoz Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin
    5.14 Vetter
        5.14.1 Vetter Company Profile
        5.14.2 Vetter Biological API Drug Manufacturing Market Product Specification
        5.14.3 Vetter Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin
    5.15 Wuxi Biologics
        5.15.1 Wuxi Biologics Company Profile
        5.15.2 Wuxi Biologics Biological API Drug Manufacturing Market Product Specification
        5.15.3 Wuxi Biologics Biological API Drug Manufacturing Market Production Capacity, Revenue, Price and Gross Margin
6. North America
    6.1 North America Biological API Drug Manufacturing Market Market Size
    6.2 North America Biological API Drug Manufacturing Market Key Players in North America
    6.3 North America Biological API Drug Manufacturing Market Market Size by Type
    6.4 North America Biological API Drug Manufacturing Market Market Size by Application
7. East Asia
    7.1 East Asia Biological API Drug Manufacturing Market Market Size
    7.2 East Asia Biological API Drug Manufacturing Market Key Players in North America
    7.3 East Asia Biological API Drug Manufacturing Market Market Size by Type
    7.4 East Asia Biological API Drug Manufacturing Market Market Size by Application
8. Europe
    8.1 Europe Biological API Drug Manufacturing Market Market Size
    8.2 Europe Biological API Drug Manufacturing Market Key Players in North America
    8.3 Europe Biological API Drug Manufacturing Market Market Size by Type
    8.4 Europe Biological API Drug Manufacturing Market Market Size by Application
9. South Asia
    9.1 South Asia Biological API Drug Manufacturing Market Market Size
    9.2 South Asia Biological API Drug Manufacturing Market Key Players in North America
    9.3 South Asia Biological API Drug Manufacturing Market Market Size by Type
    9.4 South Asia Biological API Drug Manufacturing Market Market Size by Application
10. Southeast Asia
    10.1 Southeast Asia Biological API Drug Manufacturing Market Market Size
    10.2 Southeast Asia Biological API Drug Manufacturing Market Key Players in North America
    10.3 Southeast Asia Biological API Drug Manufacturing Market Market Size by Type
    10.4 Southeast Asia Biological API Drug Manufacturing Market Market Size by Application
11. Middle East
    11.1 Middle East Biological API Drug Manufacturing Market Market Size
    11.2 Middle East Biological API Drug Manufacturing Market Key Players in North America
    11.3 Middle East Biological API Drug Manufacturing Market Market Size by Type
    11.4 Middle East Biological API Drug Manufacturing Market Market Size by Application
12. Africa
    12.1 Africa Biological API Drug Manufacturing Market Market Size
    12.2 Africa Biological API Drug Manufacturing Market Key Players in North America
    12.3 Africa Biological API Drug Manufacturing Market Market Size by Type
    12.4 Africa Biological API Drug Manufacturing Market Market Size by Application
13. Oceania
    13.1 Oceania Biological API Drug Manufacturing Market Market Size
    13.2 Oceania Biological API Drug Manufacturing Market Key Players in North America
    13.3 Oceania Biological API Drug Manufacturing Market Market Size by Type
    13.4 Oceania Biological API Drug Manufacturing Market Market Size by Application
14. South America
    14.1 South America Biological API Drug Manufacturing Market Market Size
    14.2 South America Biological API Drug Manufacturing Market Key Players in North America
    14.3 South America Biological API Drug Manufacturing Market Market Size by Type
    14.4 South America Biological API Drug Manufacturing Market Market Size by Application
15. Rest of the World
    15.1 Rest of the World Biological API Drug Manufacturing Market Market Size
    15.2 Rest of the World Biological API Drug Manufacturing Market Key Players in North America
    15.3 Rest of the World Biological API Drug Manufacturing Market Market Size by Type
    15.4 Rest of the World Biological API Drug Manufacturing Market Market Size by Application
16 Biological API Drug Manufacturing Market Market Dynamics
    16.1 Covid-19 Impact Market Top Trends
    16.2 Covid-19 Impact Market Drivers
    16.3 Covid-19 Impact Market Challenges
    16.4 Porter?s Five Forces Analysis
18 Regulatory Information
17 Analyst's Viewpoints/Conclusions
18 Appendix
    18.1 Research Methodology
        18.1.1 Methodology/Research Approach
        18.1.2 Data Source
    18.2 Disclaimer

Market Segmentation

By Type

  • In-House Manufacturing
  • Contract Manufacturing

By Application

  • Monoclonal Antibody (mAb) Therapies
  • Vaccines
  • Insulin Therapies
  • Interferon Therapies
  • Others

Regional Analysis

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain, etc.)
  • Asia-Pacific (China, India, Japan, Southeast Asia, etc.)
  • South America (Brazil, Argentina, etc.)
  • Middle East & Africa (Saudi Arabia, South Africa, etc.)

Key Players

  • Lonza
  • Boehringer Ingelheim BioXcellence
  • Celltrion
  • DSM
  • Samsung BioLogics
  • Fujifilm Diosynth Biotechnologies
  • Cytovance Biologics
  • AbbVie
  • Baxter
  • CEPiA Sanofi
  • GSK
  • Pfizer CentreOne
  • Sandoz
  • Vetter
  • Wuxi Biologics

Upto 24 to 48 hrs (Working Hours)

Upto 72 hrs max (Working Hours) - Weekends and Public Holidays

Single User License - Allows access to only one person to the report.

Multi User License - Allows sharing with max 5 persons within organization.

Corporate License – Can be shared across entire organization.

Online Payments with PayPal

Wire Transfer / Bank Transfer

Why Choose Us

24/7 Expert Support

At ChemReports, we understand that business decisions can’t wait. Our research specialists are available anytime to answer your queries and guide you through our reports, ensuring quick and reliable assistance.

Comprehensive Market Coverage

ChemReports provides 360° market analysis across materials, technologies, and global chemical sectors—helping you make confident business decisions.

Actionable Intelligence

We turn complex data into strategic insights to support fact-based decisions, market entry strategies, and competitive analysis.

Data Privacy & Security

Your personal and business information is completely secure with us. We value your trust and ensure strict confidentiality.

Customized Research

Need tailored insights? Our analysts provide custom reports built on authentic data and aligned with your specific business goals.

FAQs

Yes, we are providing all research support to get resolve all queries and concerns regarding the report. For all our clients.
Yes, we are providing complete customization in every report to fulfill your business needs.
Yes, we are providing regional and countries level analysis in the report, please mention the countries you are looking.
Yes, we are providing a discount for individuals and startups.
We offer access to more than one million market research reports. If the specific topic you need is not listed on our website, simply email us your requirements at sales@chemreports.com. Our research team will review your request and provide a customized report or the most relevant available study. We?re always happy to assist you with tailored solutions.